Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 792.90
-6.30 (-0.79%)
Nov 11, 2026, 1:00 PM IST
Granules India Market Cap
Granules India has a market cap or net worth of 195.91 billion as of November 10, 2026. Its market cap has increased by 46.75% in one year.
Market Cap
195.91B
Enterprise Value
191.89B
Revenue
58.95B
Global Rank
n/a
Country Rank
n/a
PE Ratio
27.76
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 195.91B, an increase of 119,577.85%. That is a compound annual growth rate of 34.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 195.91B | 34.88% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 420.14B |
| Ajanta Pharma | 417.97B |
| Wockhardt | 330.18B |
| Piramal Pharma | 326.07B |
| Alembic Pharmaceuticals | 200.30B |
| Alivus Life Sciences | 181.09B |
| Eris Lifesciences | 174.19B |
| Cohance Lifesciences | 169.68B |